- Home
- PRTA vs PMT Comparison
PRTA vs PMT Comparison
Compare PRTA & PMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- PMT
- Stock Information
- Founded
- PRTA 2012
- PMT 2009
- Country
- PRTA Ireland
- PMT United States
- Employees
- PRTA N/A
- PMT N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- PMT Real Estate Investment Trusts
- Sector
- PRTA Health Care
- PMT Real Estate
- Exchange
- PRTA Nasdaq
- PMT Nasdaq
- Market Cap
- PRTA 1.2B
- PMT 1.2B
- IPO Year
- PRTA N/A
- PMT 2009
- Fundamental
- Price
- PRTA $21.89
- PMT $14.24
- Analyst Decision
- PRTA Buy
- PMT Buy
- Analyst Count
- PRTA 7
- PMT 7
- Target Price
- PRTA $58.83
- PMT $14.93
- AVG Volume (30 Days)
- PRTA 255.3K
- PMT 639.3K
- Earning Date
- PRTA 10-31-2024
- PMT 10-24-2024
- Dividend Yield
- PRTA N/A
- PMT 11.28%
- EPS Growth
- PRTA N/A
- PMT 137.43
- EPS
- PRTA N/A
- PMT 1.59
- Revenue
- PRTA $217,246,000.00
- PMT $543,769,000.00
- Revenue This Year
- PRTA $59.66
- PMT N/A
- Revenue Next Year
- PRTA N/A
- PMT $12.55
- P/E Ratio
- PRTA N/A
- PMT $8.91
- Revenue Growth
- PRTA 276.98
- PMT N/A
- 52 Week Low
- PRTA $18.69
- PMT $10.52
- 52 Week High
- PRTA $55.89
- PMT $15.89
- Technical
- Relative Strength Index (RSI)
- PRTA 58.55
- PMT 60.81
- Support Level
- PRTA $20.15
- PMT $13.68
- Resistance Level
- PRTA $22.83
- PMT $13.86
- Average True Range (ATR)
- PRTA 0.82
- PMT 0.17
- MACD
- PRTA 0.13
- PMT 0.02
- Stochastic Oscillator
- PRTA 82.66
- PMT 89.83
About PRTA Prothena Corporation plc
Prothena Corp PLC is a biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating rare neurodegenerative and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including psoriasis and psoriatic arthritis (PRX003) and ATTR amyloidosis (PRX004).
About PMT PennyMac Mortgage Investment Trust of Beneficial Interest
PennyMac Mortgage Investment Trust is a specialty finance company that invests primarily in residential mortgage loans and mortgage-related assets. The company's operations include activities such as the production and servicing of financial securities based on residential loans and the pooling and reselling of high-credit-quality mortgages. The company operates through four segments: correspondent production, credit-sensitive strategies, interest-rate-sensitive strategies, and corporate activities. The Credit sensitive strategies segment generates income via investments in CRT arrangements, subordinate MBS, distressed loans, and real estate.